- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01469403
Weight Loss Intervention Before Total Knee Replacement
Weight Loss Intervention Before Total Knee Replacement, a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background In Denmark the numbers of primary total knee arthroplasty (TKA) operations annually increase. In the year 2000 was performed approximately 2,500 operations and in 2008 was performed more than 7,500 total knee arthroplasty operations, and there appears in all countries to be similar tendency. Meanwhile, the prevalence of overweight and obesity has increased markedly over the last 50 years. Approximately 13% of the Danish population is obese. For several years the association between obesity and knee osteoarthritis (OA) has been recognized, and osteoarthritis is the most frequent indication for total knee arthroplasty(80%).
The purpose of this study is to investigate whether weight loss interventions before primary total knee arthroplasty will improve quality of life and functional level, reduce pain and risk of early and late postoperative complications.
Sample size Significance level is set to 5% by using a 2-sided analysis and the power is set at 80%. Based on an expectation of a difference in patient-reported outcome scores in between the groups at 8%, as measured by SF-36 12 months postoperatively, standard deviation (SD) 13 must be include 41 participants in each group. To allow a drop-out rate of 20% the group size increases to 51 participants in each group. In total 102 participants.
Statistical analysis, The two groups scores at 12 months postoperatively, and the two groups' change in the primary outcome measurer, from 1 week before surgery to 12 months postoperatively, compared with t-test or Mann-Whitney test rang sum depending on data distribution.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Department of Orthopedics Research Aarhus University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients recommended for primary total knee replacement.
- Body mass index > 30.
- Must be motivated for weight loss.
- Must be able to read and understand Danish.
Exclusion Criteria:
- Rheumatoid arthritis.
- Patients who are operated on both knees during the project period can only participate once.
- Planned obesity surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control group
Standard procedure for knee arthroplasty
|
|
Active Comparator: Weight loss program
The intervention program consists of 8 weeks of low-diet, using formula foods, and dietary counseling before surgery.
When using formula foods the patients can achieve a quicker weight reduction and a greater reduction in fat mass than using conventional dietetic hypo caloric diet.
|
Fast weight losses improve the prognosis for the sustained weight loss.
During the first week a dietitian will tutor the participants in formula food diet (The Cambridge Health and Weight plan UK.), followed by seven weeks with control guidance and instruction in healthy eating habits once a week.
The guidance by the dietitian will be carried out both on an individual basis and in groups.
The goal of the intervention is to achieve a preoperative weight loss of at least 5 to 10% of the patient's body weight, thus improving patient's health before surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-36
Time Frame: Measured 12 months postoperatively.
|
A patient reported outcome (PRO).
The questionnaire is a tool for measuring health status.
The form is used to measure the patient's view of his own health by scoring standardized responses to standardized questions.
The schedule consists of 36 questions representing eight health concepts.
|
Measured 12 months postoperatively.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 minutes walk test (6MW).
Time Frame: Measured 1 week before surgery.
|
Used to target the operating level of the patient's daily activities.
|
Measured 1 week before surgery.
|
Body composition
Time Frame: Measured 1 week before surgery.
|
Dual energy X-ray absorptiometry (DEXA) can measure total body bone mineral density and obtain accurate measurements of body tissue composition (muscle mass and fat mass).
By measuring the body's muscle mass, fat mass and bone mineral density, one can estimate total body fat percentage.
|
Measured 1 week before surgery.
|
Bone mineral density (BMD).
Time Frame: Measured 12 months postoperatively.
|
Measured by DEXA scan.
|
Measured 12 months postoperatively.
|
KOOS
Time Frame: Measured 1 week before surgery.
|
Knee - specific patient-reported outcome that measures the patient's own assessment of knee problems and related problems.
The schedule consists of 42 questions representing 5 strands.
|
Measured 1 week before surgery.
|
Pain
Time Frame: Measured 1 week before surgery.
|
Visual Analogue Scale (VAS pain score)
|
Measured 1 week before surgery.
|
Serum leptin.
Time Frame: Measured 1 week before surgery.
|
Leptin is a hormone produced in fat tissue.
|
Measured 1 week before surgery.
|
Heart rate
Time Frame: Measured 1 week before surgery.
|
Cardiovascular complications.
|
Measured 1 week before surgery.
|
Blood pressure
Time Frame: Measured 1 week before surgery.
|
Cardiovascular complications.
|
Measured 1 week before surgery.
|
6 minutes walk test (6MW).
Time Frame: Measured 8 week postoperatively.
|
Used to target the operating level of the patient's daily activities.
|
Measured 8 week postoperatively.
|
6 minutes walk test (6MW).
Time Frame: Measured 12 months postoperatively
|
Used to target the operating level of the patient's daily activities.
|
Measured 12 months postoperatively
|
Body composition
Time Frame: Measured 8 week postoperatively
|
Dual energy X-ray absorptiometry (DEXA) can measure total body bone mineral density and obtain accurate measurements of body tissue composition (muscle mass and fat mass).
By measuring the body's muscle mass, fat mass and bone mineral density, one can estimate total body fat percentage.
|
Measured 8 week postoperatively
|
Body composition
Time Frame: Measured 12 months postoperatively
|
Dual energy X-ray absorptiometry (DEXA) can measure total body bone mineral density and obtain accurate measurements of body tissue composition (muscle mass and fat mass).
By measuring the body's muscle mass, fat mass and bone mineral density, one can estimate total body fat percentage.
|
Measured 12 months postoperatively
|
KOOS
Time Frame: Measured 8 week postoperatively
|
Knee - specific patient-reported outcome that measures the patient's own assessment of knee problems and related problems.
The schedule consists of 42 questions representing 5 strands.
|
Measured 8 week postoperatively
|
KOOS
Time Frame: Measured 12 months postoperatively
|
Knee - specific patient-reported outcome that measures the patient's own assessment of knee problems and related problems.
The schedule consists of 42 questions representing 5 strands.
|
Measured 12 months postoperatively
|
Pain
Time Frame: Measured 8 week postoperatively
|
Visual Analogue Scale (VAS pain score)
|
Measured 8 week postoperatively
|
Pain
Time Frame: Measured 12 months postoperatively
|
Visual Analogue Scale (VAS pain score)
|
Measured 12 months postoperatively
|
Serum leptin.
Time Frame: Measured 8 week postoperatively
|
Leptin is a hormone produced in fat tissue.
|
Measured 8 week postoperatively
|
Serum leptin.
Time Frame: Measured 12 months postoperatively
|
Leptin is a hormone produced in fat tissue.
|
Measured 12 months postoperatively
|
Heart rate
Time Frame: Measured 8 week postoperatively
|
Cardiovascular complications.
|
Measured 8 week postoperatively
|
Heart rate
Time Frame: Measured 12 months postoperatively
|
Cardiovascular complications.
|
Measured 12 months postoperatively
|
Blood pressure
Time Frame: Measured 8 week postoperatively
|
Cardiovascular complications.
|
Measured 8 week postoperatively
|
Blood pressure
Time Frame: Measured 12 months postoperatively
|
Cardiovascular complications.
|
Measured 12 months postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kjeld Søballe, Prof. D.Msc, Department of Orthopedics Research Aarhus University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TKABMI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on 8 weeks weight loss program, Cambridge.
-
University of ValenciaGeneralitat ValencianaRecruitingBreast Cancer Female | Autonomic Dysfunction | Cardiovascular Diseases in Old Age | Cardiometabolic Syndrome | Metabolism Disorder, LipidSpain
-
University of North Carolina, Chapel HillCompletedOverweight and ObesityUnited States
-
VA Office of Research and DevelopmentBaltimore VA Medical Center; South Texas Veterans Health Care SystemNot yet recruitingObesity | Post-COVID ConditionsUnited States
-
Rush University Medical CenterCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Healthways, Inc.Completed
-
Henning BliddalCambridge Weight Plan Limited; Oak Foundation; The Danish Rheumatism AssociationCompleted
-
The Hospital of VestfoldRoede ASActive, not recruiting